Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DINESH KAPUR

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1538144522
CMS profile
115187
Location
NORWICH, CT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$35,587.41

215 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 5; records 51–100 of 215 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DINESH KAPUR

NPI 1538144522 · CMS profile ID 115187

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

NORWICH, CT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 5; records 51–100 of 215 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1538144522?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DINESH KAPUR, NPI 1538144522, CMS profile ID 115187. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 215 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1538144522?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). DINESH KAPUR, NPI 1538144522, CMS profile ID 115187. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 215 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1538144522?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
DINESH KAPUR, NPI 1538144522, CMS profile ID 115187, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 5; records 51–100 of 215 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1538144522?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

215 matching records · $35,587.41 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 215 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 215.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $15.8609/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105271617 CMS
Rigel Pharmaceuticals, Inc. $19.4509/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145207167 CMS
Rigel Pharmaceuticals, Inc. $9.7109/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145207169 CMS
GENZYME CORPORATION $15.7309/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139651275 CMS
GlaxoSmithKline, LLC. $22.3709/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116429088 CMS
Merck Sharp & Dohme LLC $14.9709/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141753026 CMS
Novartis Pharmaceuticals Corporation $20.7109/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087072896 CMS
E.R. Squibb & Sons, L.L.C. $127.0209/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101292064 CMS
E.R. Squibb & Sons, L.L.C. $757.3409/19/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101292068 CMS
AstraZeneca Pharmaceuticals LP $20.1909/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104239217 CMS
Genentech USA, Inc. $22.9609/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133002301 CMS
Janssen Biotech, Inc. $20.7509/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078383255 CMS
Rigel Pharmaceuticals, Inc. $25.1709/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145203633 CMS
ABBVIE INC. $23.3709/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104031829 CMS
Eisai Inc. $23.8709/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110742035 CMS
Karyopharm Therapeutics Inc. $15.3809/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145529229 CMS
Celgene Corporation $19.8509/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101100969 CMS
E.R. Squibb & Sons, L.L.C. $22.3509/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101292032 CMS
E.R. Squibb & Sons, L.L.C. $8.6208/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101292034 CMS
Gilead Sciences, Inc. $23.9408/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133793781 CMS
JAZZ PHARMACEUTICALS INC. $17.7108/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150219423 CMS
Alexion Pharmaceuticals, Inc. $17.8008/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093930688 CMS
Bayer Healthcare Pharmaceuticals Inc. $14.7608/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086199230 CMS
Novartis Pharmaceuticals Corporation $15.7208/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087072894 CMS
Daiichi Sankyo Inc. $13.1208/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089440463 CMS
Celgene Corporation $20.3008/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101100965 CMS
Lilly USA, LLC $16.3508/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136168232 CMS
E.R. Squibb & Sons, L.L.C. $3.1108/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101292052 CMS
E.R. Squibb & Sons, L.L.C. $13.8008/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101292054 CMS
PFIZER INC. $22.9408/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131905253 CMS
Janssen Biotech, Inc. $27.2908/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078383278 CMS
PharmaEssentia USA Corporation $21.4908/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137303010 CMS
ARRAY BIOPHARMA INC $16.5408/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131905256 CMS
Astellas Pharma US Inc $17.1708/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139393204 CMS
Regeneron Healthcare Solutions, Inc. $19.3108/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114082187 CMS
Astellas Pharma US Inc $99.9908/06/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139381148 CMS
ABBVIE INC. $17.1208/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104031827 CMS
GENZYME CORPORATION $13.7508/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139651245 CMS
ADC Therapeutics America, Inc. $24.8307/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1121191291 CMS
ARRAY BIOPHARMA INC $20.3307/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131335591 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.8007/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086143665 CMS
PFIZER INC. $15.0007/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131795199 CMS
Merck Sharp & Dohme LLC $17.5407/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141940099 CMS
ABBVIE INC. $14.8707/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104031825 CMS
Janssen Biotech, Inc. $5.5807/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078383470 CMS
PFIZER INC. $20.8707/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131795461 CMS
E.R. Squibb & Sons, L.L.C. $300.0007/22/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101292092 CMS
Novartis Pharmaceuticals Corporation $9.0607/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087072890 CMS
E.R. Squibb & Sons, L.L.C. $8.9907/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101292028 CMS
Gilead Sciences, Inc. $24.4807/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133793779 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $97,290.65 181
PY2020 $8,367.28 71
PY2021 $10,013.36 74
PY2022 $28,897.52 109
PY2023 $10,711.94 162
PY2024 $35,587.41 215
PY2025 $9,650.92 198

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $6,490.00 15
PY2024 Principal investigator $930.17 1
PY2023 Principal investigator $0.01 1
PY2022 Principal investigator $40,763.80 5
PY2021 Principal investigator $39,703.40 6
PY2020 Principal investigator $28,100.36 11
PY2019 Principal investigator $15,605.76 5

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

15 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 GlaxoSmithKline, LLC. $1,923.75 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192167840
Principal investigator 1 GlaxoSmithKline, LLC. $68.85 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192167844
Principal investigator 1 GlaxoSmithKline, LLC. $150.00 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192167848
Principal investigator 1 GlaxoSmithKline, LLC. $125.00 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192167852
Principal investigator 1 GlaxoSmithKline, LLC. $250.00 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192167856
Principal investigator 1 GlaxoSmithKline, LLC. $750.00 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192167861
Principal investigator 1 GlaxoSmithKline, LLC. $250.00 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192167865
Principal investigator 1 GlaxoSmithKline, LLC. $250.00 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192167869
Principal investigator 1 GlaxoSmithKline, LLC. $148.50 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192168725
Principal investigator 1 GlaxoSmithKline, LLC. $150.00 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192168729
Principal investigator 1 GlaxoSmithKline, LLC. $925.00 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192168732
Principal investigator 1 GlaxoSmithKline, LLC. $549.45 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192168737
Principal investigator 1 GlaxoSmithKline, LLC. $150.00 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192168741
Principal investigator 1 GlaxoSmithKline, LLC. $549.45 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192168744
Principal investigator 1 GlaxoSmithKline, LLC. $250.00 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192168748